Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial

Two weeks of prostate cancer radiotherapy still saves lives, study finds

Treatment reduced from eight weeks without more side effects described as ‘fantastic’

Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial

The phase III study shows that giving prostate cancer patients fewer, higher doses of radiotherapy can be safe and effective in the long term.

Breaking Down the Benefits of Clinical Trial Participation in Cancer Care

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.

Colombian urologist Francisco Javier Usubillaga clarifies the true effects of consuming this beverage on prostate health. Beer is often present in many people's most relaxing and fun moments, especially at meetings with friends. However, there is concern about how its consumption may affect health, especially for men, after a certain age.

Bacteria Found to Drive Prostate Cancer Progression

Discover the role of commensal bacteria in the progression of prostate cancer and the potential treatment impacts.

Novel AI Biomarker Helps Tailor Hormone Therapy Duration for Better Outcomes in Prostate Cancer

AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from extended hormone therapy.